TruDiagnostic
TruDiagnostic is a private epigenetic diagnostics company that sells at-home DNA methylation-based biological age tests and biomarker panels to health-conscious consumers, healthcare providers, and academic researchers via proprietary algorithms co-developed with Harvard and Yale universities.
- Company typePrivate
- Founded2019
- HeadquartersLexington, United States
- Headcount51–100
- GTM typeB2B and B2C
- OfferingServices
What TruDiagnostic does
TruDiagnostic is a privately held biodata and epigenetic diagnostics company founded in 2019 and headquartered in Lexington, Kentucky, with 51-100 employees. It operates a CLIA-certified, HIPAA-compliant laboratory and sells direct-to-consumer at-home biological age testing kits through its e-commerce storefront (shop.trudiagnostic.com), a healthcare provider portal for clinical practices, and an Impact-powered affiliate channel, with the TruAge™ test priced at $499 one-time or $179.90/year subscription and the TruHealth™ panel (105+ biomarkers) and combined bundle (180+ biomarkers) rounding out the catalog. The core technology is Illumina EPIC array-based DNA methylation analysis measuring over 100,000 CpG sites, which feeds a proprietary algorithm stack including OMICmAge (co-developed with Harvard University, integrating methylation with proteomic, metabolomic, and clinical data and validated across 36,000+ individuals), SYMPHONYAge (organ-specific aging across 11 body systems, from Yale University), and an exclusively licensed DunedinPACE pace-of-aging algorithm.
TruDiagnostic firmographics
Firmographics- Name
- TruDiagnostic
- Legal name
- TruDiagnostic, LLC
- Website
- https://trudiagnostic.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- TruDiagnostic is a private epigenetic diagnostics company that sells at-home DNA methylation-based biological age tests and biomarker panels to health-conscious consumers, healthcare providers, and academic researchers via proprietary algorithms co-developed with Harvard and Yale universities.
- Ownership category
- akta.pro rank
TruDiagnostic industry classification
Industry- Product category
- Epigenetic Testing Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Epigenomics & Chromatin Profiling Services (HLAGANAF)
- akta.pro secondary industries
- Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Proteomics & Mass Spectrometry Services (HLAGANAB)
Keywords
Where TruDiagnostic is headquartered
LocationHeadquarters
- HQ city
- Lexington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
TruDiagnostic business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Direct-to-Consumer Epigenetic Testing: One-time purchase of at-home test kits with results delivered via digital dashboard. Initial purchase at $499 with optional subscription at $179.90 for ongoing tracking and updates.
- Annual Subscription: Subscription model for continued access to updated reports, longitudinal tracking, and new algorithm releases. All sales final per refund policy.
- Healthcare Provider Services: B2B laboratory services for healthcare providers including patient epigenetic testing through provider portal with HIPAA-compliant data handling.
- NIH-Funded Research: SBIR grant funding from National Institutes of Health for developing new epigenetic diagnostic models. Subject to NIH FCOI policy compliance.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | TruAge Test - One-time purchase |
| Subscription | Annual | TruAge Test - Annual Subscription |
| One time/ perpetual license | Pay-as-you-go | TruHealth Test |
| One time/ perpetual license | Pay-as-you-go | TruAge + TruHealth Combo |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
TruDiagnostic product offering
Product offeringCore offering
TruDiagnostic sells at-home epigenetic and biomarker test kits—primarily the TruAge™ biological age test, the TruHealth™ nutritional/biological systems test, and a combined bundle—processed in its CLIA-certified Lexington, Kentucky laboratory using Illumina EPIC array DNA methylation analysis. It also provides B2B clinical laboratory services to healthcare providers, research collaborations to academic institutions, and grant-funded research to develop new epigenetic diagnostic models. The company operates what it describes as the world's largest private DNA methylation dataset and licenses/exclusively licenses proprietary algorithms (OMICmAge, DunedinPACE, SYMPHONYAge) to power its reports.
Product overview
TruDiagnostic offers a multi-tiered platform of epigenetic testing products designed for at-home biological age assessment and longevity tracking. The core offerings include TruAge™ (epigenetic biological age testing), TruHealth™ (nutritional and systems health testing), and their combined bundle. TruAge measures biological age using proprietary algorithms including OMICmAge™ (developed with Harvard University), DunedinPACE™ (exclusively licensed), and SYMPHONYAge™ (from Yale University), analyzing over 100,000 DNA methylation markers. TruHealth complements this with 105+ biomarkers for nutritional, metabolic, immune, and cognitive health assessment. The platform is CLIA certified, HSA/FSA accepted, and designed for direct-to-consumer use with at-home sample collection kits priced at $499 for TruAge with subscription options available.
Differentiator
Problem solved
Functional benefit
Brands
- TruAge™: Epigenetic test measuring biological age at the cellular level, including OMICmAge, DunedinPACE, SYMPHONYAge, and various health risk assessments.
- TruHealth™
- TruAge + TruHealth™
Products and services
- TruAge™ Test
Quantifiable outcome
- 32-week semaglutide study showed average biological age reversal of 3.1 years and 9% slowing of aging rate
- +1 more outcomes
Companies that use TruDiagnostic
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
TruDiagnostic technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature6 records
TruDiagnostic partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered flagship and core.
- TMRWflagshipExclusive Australian partnership where TMRW longevity platform provides TruDiagnostic's epigenetic testing services to Australian members. TruDiagnostic gains market access while TMRW offers comprehensive longevity diagnostics.
- Harvard UniversitycoreCollaborative development of OMICmAge, a multi-omic biological aging biomarker that integrates DNA methylation with proteomic, metabolomic, and clinical data. Partnership leverages Harvard research expertise with TruDiagnostic's proprietary database.
- Yale UniversitycoreLicensing and development of SYMPHONYAge clock series providing organ-specific epigenetic aging algorithms across 11 body systems including brain, heart, liver, and lungs.
- Dunededin Study (University of Otago)coreExclusively licensed DunedinPACE algorithm from the Dunedin Multidisciplinary Health and Development Study for pace of aging measurement.
- North Carolina State UniversitycoreCollaboration to fully characterize all imprinting control regions and develop novel Imprintome epigenetic methylation array for testing.
- Cornell UniversitycoreUniversity partnership for research and licensing opportunities in epigenetics and aging research.
- Duke UniversitycoreUniversity partnership for research and licensing opportunities in epigenetics and aging research.
- University Partnerships (20+)coreActive partnerships with over 20 renowned universities for research collaborations and licensing opportunities in epigenetic science.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
TruDiagnostic competitors and assessment
Company assessmentDirect peers
- Elysium Health: Elysium's Index product is a direct-to-consumer epigenetic age test built on Illumina EPIC arrays—the closest head-to-head competitor to TruDiagnostic's TruAge. Both compete for the same biohacker and longevity consumer with methylation-based biological age reports.
- Tally Health: Tally Health offers a consumer longevity membership with biological age testing and clinical protocols. It was acquired by TruDiagnostic in April 2026, but operationally its consumer offering is structurally identical to TruDiagnostic's DTC longevity positioning.
- NOVOS: NOVOS sells longevity supplements bundled with a biological age testing program including epigenetic measures. It targets the same biohacker and longevity consumer with a combined supplement-and-test value proposition that overlaps with TruDiagnostic's wellness-oriented customer base.
- GlycanAge: GlycanAge offers a direct-to-consumer biological age test based on immunoglobulin G glycan analysis. It competes for the same longevity-conscious consumer seeking objective biological age measurement, using a complementary but substitutable biomarker approach to DNA methylation.
- InsideTracker: InsideTracker provides personalized biomarker analysis from blood tests with longevity and performance-oriented dashboards. It competes with TruDiagnostic's TruHealth panel for consumers seeking data-driven health optimization, though its core modality is blood biomarkers rather than epigenetics.
Emerging players
- Function Health: Function Health offers comprehensive annual blood biomarker testing with a longevity framing and physician-led review. It addresses a similar health-optimization consumer with broader lab panels, making it a partial substitute for TruDiagnostic's premium testing bundles.
- Viome: Viome sells direct-to-consumer gut microbiome and transcriptomic testing with personalized nutrition recommendations and a 'biological age' framing. It overlaps with TruDiagnostic's preventive-health, multi-omic consumer value proposition though its core analyte is the microbiome.
Broad incumbents
- Human Longevity Inc. Human Longevity offers whole-genome sequencing, advanced imaging, and comprehensive biomarker panels in a premium executive-health membership. It overlaps with TruDiagnostic's premium longevity diagnostics segment with a broader (and more expensive) clinical-grade offering.
- Genova Diagnostics: Genova Diagnostics is an established specialty clinical laboratory offering advanced biomarker, genomic, and functional testing through healthcare providers. It competes for TruDiagnostic's healthcare-provider channel with a deeper, more clinically entrenched footprint.
Others
- Zymo Research: Zymo Research supplies epigenetic research reagents, kits, and services (including DNA methylation arrays and analysis) used by academic and clinical labs. It is an enabling technology provider in the same epigenetic workflow that TruDiagnostic's lab depends on, rather than a direct consumer competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
TruDiagnostic social profiles
Digital presenceTruDiagnostic compliance and trust
Trust signalCompliance2 records
TruDiagnostic financial estimates
Financial estimateRevenue estimate
Valuation estimate
TruDiagnostic leadership team
Management profileNumber of profiles
Profiles1 record
TruDiagnostic funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TruDiagnostic M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TruDiagnostic
What does TruDiagnostic do?
TruDiagnostic sells at-home epigenetic and biomarker test kits—primarily the TruAge™ biological age test, the TruHealth™ nutritional/biological systems test, and a combined bundle—processed in its CLIA-certified Lexington, Kentucky laboratory using Illumina EPIC array DNA methylation analysis. It also provides B2B clinical laboratory services to healthcare providers, research collaborations to academic institutions, and grant-funded research to develop new epigenetic diagnostic models. The company operates what it describes as the world's largest private DNA methylation dataset and licenses/exclusively licenses proprietary algorithms (OMICmAge, DunedinPACE, SYMPHONYAge) to power its reports.
Is TruDiagnostic a public or private company?
TruDiagnostic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was TruDiagnostic founded?
TruDiagnostic was founded in 2019. It employs 51 to 100 people.
Where is TruDiagnostic based?
TruDiagnostic is headquartered in Lexington, United States, in the North America region.
How does TruDiagnostic make money?
Four revenue lines are on record. Direct-to-Consumer Epigenetic Testing is the primary driver. The others are annual Subscription, healthcare Provider Services and NIH-Funded Research.
Who are TruDiagnostic's main competitors?
Direct peers on record are Elysium Health, Tally Health, NOVOS, GlycanAge and InsideTracker. Emerging players are Function Health and Viome. Broad incumbents are Human Longevity Inc. and Genova Diagnostics. Zymo Research is listed as an others.
Does TruDiagnostic have an API?
Yes. TruDiagnostic offers an API Reference accessible at https://trudiagnostic.notion.site/Tru-Diagnostic-v2-API-100865e61b7e803fa038dee5e55e6cc2 for developers and partners. The API is designed for healthcare providers and commercial partners to programmatically access TruDiagnostic's epigenetic testing services, including data retrieval and programmatic integration capabilities. Developer documentation is at trudiagnostic.notion.site/Tru-Diagnostic-v2-API-100865e61b7e803fa038dee5e55e6cc2.
What industry is TruDiagnostic in?
TruDiagnostic's product category is Epigenetic Testing Services. Its primary akta.pro industry code is HLAGANAF, Epigenomics & Chromatin Profiling Services, with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 621511 and its SIC code is 8071.